Trial intelligence / Profile preview

Pulsed dye laser with topical sirolimus versus placebo for port-wine stain

IRCT20170617034590N2Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of sirolimus in port-wine stain, sponsored by Tehran University of Medical Sciences. Primary endpoint: Reduction in lesion erythema. Started Oct 2017; status: completed.

02

Drugs

sirolimus
03

Conditions

port-wine stain

Beyond the preview

Go deeper on IRCT20170617034590N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170617034590N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call